These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22670865)

  • 21. Would alternate tobacco products use be better than smoking?
    Martinet Y; Bohadana A; Fagerström K
    Lung Cancer; 2006 Jul; 53(1):1-4. PubMed ID: 16690160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tobacco Harm Reduction with Vaporised Nicotine (THRiVe): The Study Protocol of an Uncontrolled Feasibility Study of Novel Nicotine Replacement Products among People Living with HIV Who Smoke.
    Bell S; Dean J; Gilks C; Boyd MA; Fitzgerald L; Mutch A; Baker P; Neilsen G; Gartner CE
    Int J Environ Res Public Health; 2017 Jul; 14(7):. PubMed ID: 28718828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smokers can use nicotine replacement products to reduce harm, says NICE.
    Iacobucci G
    BMJ; 2013 Jun; 346():f3663. PubMed ID: 23737358
    [No Abstract]   [Full Text] [Related]  

  • 25. Association between tobacco industry denormalization beliefs, tobacco control community discontent and smokers' level of nicotine dependence.
    Kushnir V; Selby P; Cunningham JA
    Addict Behav; 2013 Jul; 38(7):2273-8. PubMed ID: 23583832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoting positive attitudes of tobacco-dependent mental health patients towards NRT-supported harm reduction and smoking cessation.
    Bittoun R; Barone M; Mendelsohn CP; Elcombe EL; Glozier N
    Aust N Z J Psychiatry; 2014 Oct; 48(10):954-6. PubMed ID: 24907132
    [No Abstract]   [Full Text] [Related]  

  • 28. Adolescent tobacco use and dependence: assessment and treatment strategies.
    Ziedonis D; Haberstroh S; Hanos Zimmermann M; Miceli M; Foulds J
    Adolesc Med Clin; 2006 Jun; 17(2):381-410. PubMed ID: 16814699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing tobacco harm: research challenges and issues.
    Hatsukami DK; Slade J; Benowitz NL; Giovino GA; Gritz ER; Leischow S; Warner KE
    Nicotine Tob Res; 2002; 4 Suppl 2():S89-101. PubMed ID: 12573171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community tobacco control leaders' perceptions of harm reduction.
    Joseph AM; Hennrikus D; Thoele MJ; Krueger R; Hatsukami D
    Tob Control; 2004 Jun; 13(2):108-13. PubMed ID: 15175521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smokers' interest in using nicotine replacement to aid smoking reduction.
    Shiffman S; Hughes JR; Ferguson SG; Pillitteri JL; Gitchell JG; Burton SL
    Nicotine Tob Res; 2007 Nov; 9(11):1177-82. PubMed ID: 17978992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. POINT: e-Cigarette Use for Harm Reduction in Tobacco Use Disorder? Yes.
    Bates CD
    Chest; 2021 Sep; 160(3):807-809. PubMed ID: 34488958
    [No Abstract]   [Full Text] [Related]  

  • 33. 'Every space is claimed': smokers' experiences of tobacco denormalisation.
    Bell K; McCullough L; Salmon A; Bell J
    Sociol Health Illn; 2010 Sep; 32(6):914-29. PubMed ID: 20525013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence, Policy, and E-Cigarettes--Will England Reframe the Debate?
    Green SH; Bayer R; Fairchild AL
    N Engl J Med; 2016 Apr; 374(14):1301-3. PubMed ID: 27050203
    [No Abstract]   [Full Text] [Related]  

  • 36. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the efficacy and effectiveness of harm reduction strategies for alcohol, tobacco and illicit drugs.
    Ritter A; Cameron J
    Drug Alcohol Rev; 2006 Nov; 25(6):611-24. PubMed ID: 17132577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What do persons with mental illnesses need to quit smoking? Mental health consumer and provider perspectives.
    Morris CD; Waxmonsky JA; May MG; Giese AA
    Psychiatr Rehabil J; 2009; 32(4):276-84. PubMed ID: 19346206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Planned quit attempts among Ontario smokers: impact on abstinence.
    Sendzik T; McDonald PW; Brown KS; Hammond D; Ferrence R
    Addiction; 2011 Nov; 106(11):2005-13. PubMed ID: 21592249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.